Publications by authors named "Masami Morimoto"

Claim this Profile
P
Phase 1 Dose-Escalation Study of Triweekly Nab-Paclitaxel Combined With S-1 for HER2-Negative Metastatic Breast Cancer.
Masami Morimoto, Hiroaki Toba, Mariko Aoyama, Misako Nakagawa, Hirokazu Takechi

Clin Breast Cancer· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bronchioalveolar stem cells derived from mouse-induced pluripotent stem cells promote airway epithelium regeneration.
Naoya Kawakita, Hiroaki Toba, Keiko Miyoshi, Shinichi Sakamoto, Daisuke Matsumoto, Masami Morimoto

Stem Cell Res Ther· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prophylactic administration of granulocyte colony-stimulating factor in epirubicin and cyclophosphamide chemotherapy for Japanese breast cancer patients: a retrospective study.
Takumi Sakurada, Sanako Bando, Yoshito Zamami, Kenshi Takechi, Masayuki Chuma, Masami Morimoto

Cancer Chemother Pharmacol· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II Study of S-1 Combined With Low-Dose Docetaxel as Neoadjuvant Chemotherapy for Operable Breast Cancer Patients (N-1 Study).
Misako Nakagawa, Mayumi Ikeuchi, Masami Morimoto, Hirokazu Takechi, Hiroaki Toba

Clin Breast Cancer· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Thirty percent of ductal carcinoma in situ of the breast in Japan is extremely low-grade ER(+)/HER2(-) type without comedo necrosis.
Miyuki Kanematsu, Masami Morimoto, Masako Takahashi, Junko Honda, Yoshimi Bando

J Med Invest· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assay of serum E2 concentration in postmenopausal breast cancer patients using a high-sensitivity RIA method is generally useful.
Masami Morimoto, Masako Takahashi, Junko Honda, Takahiro Yoshida, Mitsuteru Yoshida

J Med Invest· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunocytochemical results for HER2 and Ki67 in breast cancer touch-smear cell specimens are reliable.
Masami Morimoto, Yoshimi Bando, Misako Nakagawa, Hirokazu Takechi, Takahiro Yoshida

Breast Cancer· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preoperative diagnosis of sentinel lymph node (SLN) metastasis using 3D CT lymphography (CTLG).
Misako Nakagawa, Masami Morimoto, Hirokazu Takechi, Yukiko Tadokoro, Akira Tangoku

Breast Cancer· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Triple assessment of sentinel lymph node metastasis in early breast cancer using preoperative CTLG, intraoperative fluorescence navigation and OSNA.
Mohamed Mokhtar, Yukiko Tadokoro, Misako Nakagawa, Masami Morimoto, Hirokazu Takechi

Breast Cancer· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
1
18F-fluorodeoxyglucose positron emission tomography/computed tomography and the relationship between fluorodeoxyglucose uptake and the expression of hypoxia-inducible factor-1α, glucose transporter-1 and vascular endothelial growth factor in thymic epithelial tumours.
Hiroaki Toba, Kazuya Kondo, Yohei Sadohara, Hideki Otsuka, Masami Morimoto

Eur J Cardiothorac Surg· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Pathological complete response in a case of advanced esophageal cancer invading aorta treated by preoperative chemotherapy with docetaxel and cisplatin plus 5-FU].
Takeshi Nishino, Yota Yamamoto, Mayumi Ikeda, Masami Morimoto, Takako Furukawa

Gan To Kagaku Ryoho· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The new era of staging as a key for an appropriate treatment for esophageal cancer.
Akira Tangoku, Yota Yamamoto, Yoshihito Furukita, Masakazu Goto, Masami Morimoto

Ann Thorac Cardiovasc Surg· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Oral chemotherapy for advanced breast cancer].
Misako Nakagawa, Masami Morimoto, Akira Tangoku

Nihon Rinsho· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Small size lung adenocarcinoma with rocal recurrence and port site recurrence 56 months after partial resection].
Hisashi Matsuoka, Takanori Miyoshi, Masami Morimoto, Naoki Hino, Masaru Tsuyuguchi

Kyobu Geka· December 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The time since last menstrual period is important as a clinical predictor for non-steroidal aromatase inhibitor-related arthralgia.
Miyuki Kanematsu, Masami Morimoto, Junko Honda, Taeko Nagao, Misako Nakagawa

BMC Cancer· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expression of p53, Ki-67, E-cadherin, N-cadherin and TOP2A in triple-negative breast cancer.
Misako Nakagawa, Yoshimi Bando, Taeko Nagao, Masami Morimoto, Chikako Takai

Anticancer Res· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis